ARTICLE IN ACADEMIC JOURNALS
NO | DETAILS OF ARTICLE IN ACADEMIC JOURNALS |
---|---|
1. |
Synthesis and Staphylococcus aureus biofilm inhibitory activity of indolenine-substituted pyrazole and pyrimido[1,2-b]indazole derivatives
2023
Source : BIOORGANIC & MEDICINAL CHEMISTRY DOI : 10.1016/j.bmc.2023.117485 |
2. |
Automated in silico EGFR Peptide Inhibitor Elongation using Self-evolving Peptide Algorithm
2022
Author(s) : Heh Choon Han,Chin Sek Peng Source : CURRENT COMPUTER-AIDED DRUG DESIGN DOI : 10.2174/1573409918666220516144300 |
3. |
Surgical site infection and development of antimicrobial sutures: a review
2022
Source : EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES |
4. |
Protein-Protein Interactions: Insight from Molecular Dynamics Simulations and Nanoparticle Tracking Analysis
2021
Source : MOLECULES DOI : 10.3390/molecules26185696 |
5. |
Discovery of Dengue Virus Inhibitors
2020
Source : Current Medicinal Chemistry DOI : 10.2174/0929867326666181204155336 |
6. |
Loop dynamics behind the affinity of DARPins towards ERK2: Molecular dynamics simulations (MDs) and elastic network model (ENM)
2019
Author(s) : Chin Sek Peng Source : Journal of Molecular Liquids |
7. |
Dynamics and binding interactions of peptide inhibitors of dengue virus entry
2019
Source : Journal of Biological Physics DOI : 10.1007/s10867-018-9515-6 |
8. |
In vitro functional evaluation of isolaureline, dicentrine and glaucine enantiomers at 5-HT2 and alpha1 receptors
2018
Author(s) : Chin Sek Peng Source : Chem Biol Drug Des DOI : 10.1111/cbdd.13390 |
9. |
Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists
2018
Author(s) : Chin Sek Peng Source : MedChemComm DOI : 10.1039/C7MD00629B |
10. |
In silico study on anti- Chikungunya virus activity of hesperetin
2016
Author(s) : Chin Sek Peng Source : PeerJ |
11. |
In Silico and In Vitro Analysis of Bacoside A Aglycones and its Derivatives as the Constituents Responsible for the Cognitive Effects of Bacopa monnieri
2015
Author(s) : Chin Sek Peng Source : PLos One |
12. |
Toward activated homology models of the human M1 muscarinic acetylcholine receptor.
2014
Author(s) : Chin Sek Peng Source : Journal of Molecular Graphics and Modelling |
13. |
Flavonoids with M1 muscarinic acetylcholine receptor binding activity.
2014
Author(s) : Chin Sek Peng Source : Molecules |
14. |
Thermo-effects of methionine aminopeptidase: Molecular dynamics studies
2007
Author(s) : Chin Sek Peng Source : World Congress on Medical Physics and Biomedical Engineering |
RESEARCH PROJECT
GRANT | PROGRESS | STATUS |
---|---|---|
Interdisciplinary And Target-based Development Of Nutraceuticals And Drugs For Prevention And Treatments Of Diseases
Researcher(s) : Dr. Heh Choon Han,Dr. Chee Chin Fei
(RU Geran) |
|
end |
Design And Development Of Antimicrobial Molecules/anti-virulence Agents For Suppression Of Biofilm Formation Of Staphylococcus Aureus
(Others MOHE - Top 100 (IIRG)-FNW) |
|
end |
RESEARCH COLLABORATOR
GRANT | PROGRESS | STATUS |
---|---|---|
Investigating Factors Affecting Aptamer?s Conformation And Target Sensitivity At The Aptamer-graphene Interface And Mechanism Description For Biosensing Applications
Researcher(s) : Dr. Chin Sek Peng,Prof. Dr. Thong Kwai Lin,Dr. Heh Choon Han,Dr. Subhashini A/p Raj Kumal
(Fundamental Research Grant Scheme (FRGS)) |
|
on going |
WP2: Development of Novel Therapeutic Agent and Delivery Method for Lung Cancer
(Others MOHE - Top 100 (IIRG)-FNW) |
|
on going |
Understanding The Mechanism Of Extracellular Release Of ?-synuclein Through Leucine-rich Repeat Kinase 2 (lrrk2) Mutations And Kinase Inhibition
Researcher(s) : Prof. Dr. Lim Shen-yang,Dr. Chee Chin Fei,Associate Prof. Dr. Tan Ai Huey,Dr. Chin Sek Peng
(Fundamental Research Grant Scheme (FRGS)) |
|
end |
In Silico Self-evolving Peptides Algorithm For The Discovery Of Potential Peptide Inhibitor Against Alpha-amylase And Alpha-glucosidase
(Fundamental Research Grant Scheme (FRGS)) |
|
end |
Development Of Highly Potent, Selective, And Brain-penetrant Aminopyridoxamine Leucine-rich Repeat Kinase 2 (lrrk2) Inhibitors For Parkinson S Disease Treatment
(Geran Penyelidikan Universiti Malaya (UMRG) - AFR (Frontier Science)) |
|
end |
Development Of Highly Potent, Selective, And Brain-penetrant Aminopyridoxamine Leucine-rich Repeat Kinase 2 (lrrk2) Inhibitors For Parkinson S Disease Treatment
(Geran Penyelidikan Universiti Malaya (UMRG) - AFR (Frontier Science)) |
|
end |